Table 1 Patient characteristics and outcome
Pt no. | Age | Sex | VALSG stage | PS | LDH | Treatment | Best response | PFS (days) | OS (days) | Follow up (days) |
|---|---|---|---|---|---|---|---|---|---|---|
1 | 62 | f | ED | 1 | 220 | Car+eto × 6 | CR | 246 | 349 |  |
2 | 60 | f | ED | 1 | 231 | Car+eto × 6 RT 30 Gy(bone metastases) PCI | PR | 194 | 320 |  |
3 | 72 | m | ED | 1 | 216 | Car+eto × 6 | PR | 134 | 209 |  |
4 | 77 | m | ED | 1 | 354 | Car+eto × 3 | SD | 90 | 114 |  |
5 | 59 | f | ED/Relapse | 2 | 267 | Car+eto × 3 | SD | 220 | 220 |  |
6 | 58 | m | LD | 0 | 172 | Cis + eto × 2, car+eto × 2 Concomitant RT 60 Gy (RUL + mediastinum) PCI | CR | 155 |  | 741 |
7 | 76 | m | ED | 3 | 1180 | Eto × 1 RT (bone metastases) | NA* | 47 | 47 |  |
8 | 51 | f | ED | 1 | 160 | Car+eto × 6 Sequential RT 30 Gy (mediastinum) PCI | PR | 243 |  | 460 |
9 | 60 | f | ED | 1 | 264 | Car+eto × 6 | PR | 195 | 321 |  |
10 | 70 | f | ED/Relapse | 1 | 173 | Car+eto × 3 | PR | 124 | 347 |  |
11 | 59 | m | ED | 0 | 736 | Car+eto × 6 Sequential RT 30 Gy (Right lung + mediastinum) RT 30 Gy (metastases on the thoracic wall and on scull) | SD | 275 | 478 |  |
12 | 74 | m | ED | 0 | NA | Car+eto × 4 Sequential RT 30 Gy (mediastinum, neck) | PD | 50 | 95 |  |